Purchases and Sales Made in Q4 2024 in Intra Cellular Therapies, Inc. (ITCI)
This table provides information about the institutional ownership of Intra Cellular Therapies, Inc. (ITCI) during Q4 2024. The information is specifically focused on institutions that hold shares of Intra-Cellular Therapies, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-36.8K- 47.52% |
$2.62M - $3.37M
|
40.6K
$5.2M
|
|
|
Feb 12, 2025
Q4 2024
|
Clearbridge Investments, LLC
New York, NY |
SELL
|
- |
-43.3K- 2.51% |
$3.09M - $3.97M
|
1.69M
$216M
|
|
|
Feb 14, 2025
Q4 2024
|
Bellevue Group Ag
Kuesnacht, V8 |
SELL
|
- |
-45.4K- 1.83% |
$3.23M - $4.16M
|
2.44M
$312M
|
|
|
Feb 12, 2025
Q4 2024
|
Trexquant Investment LP
Stamford, CT |
SELL
|
- |
-47K- 47.18% |
$3.34M - $4.3M
|
52.6K
$6.73M
|
|
|
Feb 14, 2025
Q4 2024
|
Emerald Mutual Fund Advisers Trust
|
SELL
|
- |
-50K- 14.94% |
$3.56M - $4.58M
|
285K
$36.4M
|
|
|
Feb 06, 2025
Q4 2024
|
Edgestream Partners, L.P.
Princeton, NJ |
SELL
|
- |
-51K- 93.34% |
$3.63M - $4.67M
|
3.64K
$465K
|
|
|
Feb 14, 2025
Q4 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-58.1K- 13.76% |
$4.14M - $5.32M
|
364K
$46.6M
|
|
|
Feb 12, 2025
Q4 2024
|
Pictet Asset Management Holding Sa
Carouge, V8 |
SELL
|
- |
-78.8K- 4.87% |
$5.61M - $7.21M
|
1.54M
$197M
|
|
|
Feb 13, 2025
Q4 2024
|
Altium Capital Management LP
New York, NY |
SELL
|
- |
-79K- 51.3% |
$5.62M - $7.23M
|
75K
$9.6M
|
|
|
Feb 11, 2025
Q4 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-79.6K- 17.46% |
$5.67M - $7.29M
|
376K
$48.2M
|
|
|
Feb 13, 2025
Q4 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-81.2K- 7.0% |
$5.78M - $7.44M
|
1.08M
$138M
|
|
|
Jan 14, 2025
Q4 2024
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-86.9K- 37.29% |
$6.18M - $7.95M
|
146K
$18.7M
|
|
|
Feb 14, 2025
Q4 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-90.7K- 10.47% |
$6.46M - $8.31M
|
776K
$99.3M
|
|
|
Feb 14, 2025
Q4 2024
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
SELL
|
- |
-112K- 17.83% |
$7.98M - $10.3M
|
517K
$66.1M
|
|
|
Feb 14, 2025
Q4 2024
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-136K- 58.37% |
$9.68M - $12.5M
|
97K
$12.4M
|
|
|
Feb 14, 2025
Q4 2024
|
Hrt Financial LP
New York, NY |
SELL
|
- |
-141K- 84.39% |
$10M - $12.9M
|
26K
$3.33M
|
|
|
Feb 12, 2025
Q4 2024
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-152K- 12.56% |
$10.8M - $13.9M
|
1.06M
$135M
|
|
|
Feb 12, 2025
Q4 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-160K- 3.03% |
$11.4M - $14.7M
|
5.13M
$656M
|
|
|
Feb 14, 2025
Q4 2024
|
Macquarie Group LTD
Australia, C3 |
SELL
|
- |
-162K- 22.95% |
$11.5M - $14.8M
|
545K
$69.7M
|
|
|
Feb 14, 2025
Q4 2024
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-168K- 52.74% |
$11.9M - $15.3M
|
150K
$19.2M
|
|
|
Feb 14, 2025
Q4 2024
|
Holocene Advisors, LP
New York, NY |
SELL
|
- |
-173K- 12.59% |
$12.3M - $15.8M
|
1.2M
$153M
|
|
|
Feb 12, 2025
Q4 2024
|
Schroder Investment Management Group
London, X0 |
SELL
|
- |
-181K- 19.58% |
$12.9M - $16.6M
|
743K
$95.1M
|
|
|
Feb 14, 2025
Q4 2024
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-334K- 20.58% |
$23.8M - $30.6M
|
1.29M
$165M
|
|
|
Feb 14, 2025
Q4 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-453K- 43.41% |
$32.2M - $41.4M
|
590K
$75.5M
|
|
|
Feb 14, 2025
Q4 2024
|
Alyeska Investment Group, L.P.
Chicago, IL |
SELL
|
- |
-480K- 51.55% |
$34.2M - $44M
|
451K
$57.7M
|
|
|
Feb 13, 2025
Q4 2024
|
Wasatch Advisors Inc
Salt Lake City, UT |
SELL
|
- |
-600K- 15.58% |
$42.7M - $54.9M
|
3.25M
$416M
|